If prior exposure to LP IAV provides any immune pressure relative to such an introduction, the timing of these LP infections and the prevalence of antibodies to specific HA and NA subtypes during that year may be relevant to the potential trajectory of an introduced GsGD-HP-H5 virus. The gene discussed is HP; the disease is infection.